They found that TRIM47 expression was significantly upregulated along with the decrease of FBP1 expressions in pancreatic cancer patient tissues linking to a lower survival rate, which was also approved in pancreatic cancer cells as well (Li et al. 2021). The gene discussed is FBP1; the disease is pancreatic neoplasm.